SOM Biotech attended the BIO International Convention in Philadelphia last 3-6 June 2019. BIO is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on major trends affecting the industry. This year 4.075 companies attended with more than 7.700 delegates.
For SOM Biotech to assist every year in BIO Convention is an opportunity to build new strategic partnerships through the communication with global biotech and pharma leaders.
This year SOM Biotech had more than 40 B2B meetings with a lot of traction on its SOMAI PRO technology and assets in development, especially SOM3355 for Huntington disease and Tardive Dyskinesia.